To investigate the extent to which the proportion of schizophrenia's additive genetic variation tagged by SNPs is shared by populations of European and African descent, we analyzed the largest combined African descent (AD [n ¼ 2,142]) and European descent (ED [n ¼ 4,990]) schizophrenia case-control genome-wide association study (GWAS) data set available, the Molecular Genetics of Schizophrenia (MGS) data set. We show how a method that uses genomic similarities at measured SNPs to estimate the additive genetic correlation (SNP correlation [SNP-r g ]) between traits can be extended to estimate SNP-r g for the same trait between ethnicities. We estimated SNP-r g for schizophrenia between the MGS ED and MGS AD samples to be 0.66 (SE ¼ 0.23), which is significantly different from 0 (p (SNP-rg ¼ 0) ¼ 0.0003), but not 1 (p (SNP-rg ¼ 1) ¼ 0.26). We re-estimated SNP-r g between an independent ED data set (n ¼ 6,665) and the MGS AD sample to be 0.61
Introduction
Schizophrenia is a severe mental disorder with a lifetime prevalence around 1% and a heritability of 0.7-0.8.
1,2
Using a linear mixed model, we previously found that about a third of the genetic variation in liability to schizophrenia is captured by additive effects of common (minor allele frequency [MAF] > 0.01) SNPs in a large European case-control data set. 3 This approach first derives genetic similarities at measured SNPs among classically unrelated individuals and then uses those similarities to estimate the amount of variability explained by all SNPs together. Because rare causal variants are not well predicted by common SNPs, this finding suggests that a substantial portion of the heritability of schizophrenia is due to additive effects of common causal variants, 3 a conclusion consistent with extrapolations from results by a different methodology. 4 However, it is unclear whether this result also applies to populations of African descent and, if so, whether the proportion of schizophrenia's genetic variation tagged by SNPs is shared between populations of African descent (AD) and European descent (ED). Although rare variants (MAF < 0.01) are largely population specific, 5, 6 common variants are typically polymorphic across divergent ethnic groups; 7 therefore, it is possible that a meaningful portion of schizophrenia's genetic variation tagged by common SNPs could be shared between ED and AD individuals. However, different causal variants between ethnicities, or different linkage-disequilibrium (LD) patterns between SNPs and causal variants across ethnicities, could result in lower overlap in additive genetic variation tagged by SNPs. To date,~96% of genome-wide association study (GWAS) participants have been ED individuals. 8, 9 Because SNP associations might differ between ethnicities, genetic studies using European-only samples could yield results with a strong Eurocentric bias. 10 A traditional approach for understanding whether SNP associations are consistent across ethnicities is to assess the similarity of GWAS results among different ethnic groups [11] [12] [13] [14] . However, for most complex traits, only a small minority of truly associated SNPs reach stringent genome-wide significance thresholds, 15 and so overlap in significant associations is not necessarily expected, even if the effects of most SNPs are similar across ethnicities. In an attempt to gain insight into the overall consistency of schizophrenia SNP associations between ED and AD populations, a previous study 4 In the present study, we used a bivariate linear mixedeffects model implemented in GCTA 18 to estimate the proportion of schizophrenia-risk variation that is tagged by the additive effects of SNPs (we refer to this estimate as the SNP heritability) in predominately AD individuals (African Americans). We also estimated the additive genetic correlation tagged by SNPs (the SNP correlation) in schizophrenia between ED and AD individuals. With this approach, the effects of SNPs are treated as statistically random and individual SNP effects are not estimated, nor is there a need to prune SNPs for LD or statistical significance. Rather, all SNPs are used simultaneously for estimating genome-wide similarities between pairs of individuals; these similarity estimates are in turn used for estimating variance and covariance parameters in a linear mixed-effects model. This method does not depend on reliable estimation of individual SNP effects and so should provide unbiased estimates of the SNP heritability and SNP correlation regardless of subject sample size (larger samples should decrease the SEs of estimates).
Material and Methods

GWAS Samples and Quality Control
The MGS and International Schizophrenia Consortium (ISC) casecontrol data sets have previously been described in detail. 3, 4, 19, 20 The study and use of these data sets were approved by institutional review boards at the University of Colorado. Because MGS subjects and just over half of ISC subjects were genotyped for 909,622 autosomal SNPs (on Affy 6 Platforms), whereas just under half of ISC subjects were genotyped for~500K autosomal SNPs on earlier platforms (Affy 5 and Affy 500K), we used imputed ISC data to maximize the number of subjects included in the analysis. Therefore, we conducted the main analysis by using raw MGS and imputed ISC genotypes. We imputed ISC genotypes with HapMap 3 CEU (Utah residents with ancestry from northern and western Europe from the CEPH collection) and TSI (Toscani in Italia) populations as reference panels. 20 We imputed MGS ED genotypes in the same way to allow a comparison of results from raw and imputed data. We found no evidence that use of imputed data affected estimates of SNP heritabilities or SNP correlations; results were virtually identical across models that used imputed versus raw MGS ED data (Table S1 , available online). We did not attempt to impute MGS AD genotypes because of the difficulty of imputing admixed AD samples. 21, 22 We calculated the MAF and imputation R 2 (ratio of observed to expected variance) for each SNP for quality-control purposes. Each data set underwent stringent quality-control procedures separately. In particular, we dropped (1) individuals with average missing rates in raw SNP calls > 0.02; (2) individuals who were more than 5 SDs away from the cohort's (within data set, within ethnicity) mean scores on the first two ethnic principal components (PCs; see ''PC Analysis'' below), the first of which differentiated ED and AD individuals; and (3) one individual from each pair of individuals with genome-wide similarities > 0.05. We dropped SNPs when (1) MAF < 0.01; (2) missing rates > 0.02 (raw data only); (3) missing rate differences between cases and controls > 0.02 (raw data only); (4) SNP frequency differences to CEU HapMap > 0.15 (because AD individuals tend to be admixed, the MGS AD data set did not undergo this step); (5) HardyWeinberg equilibrium test (controls only) p < 10
À6
; and (6) imputation R 2 < 0.6 in all cohorts (imputed data only). Only SNPs in common across cohorts were kept for analysis, resulting in 477,664 SNPs. Final cohort sample sizes are summarized in Table 1 .
PC Analysis
PC analysis is used for reducing the dimensionality of data with correlated variables. When applied to genomic-similarity matrices computed from SNP data, the first several PCs typically capture ancestry differences between populations and later PCs can also capture technical batch effects. We ran PC analysis on subject pairwise genomic (identity by state [IBS]) similarities across SNPs from the combined MGS AD, MGS ED, and ISC ED samples, along with JPT, YRI, and CEU HapMap reference panels, by using a random subset of 30K SNPs that were pruned to be in linkage equilibrium and that were shared in common across samples. The use of HapMap reference panels ''anchored'' our PC results, such that the first PC (PC1) distinguished African and European ancestries and the second distinguished Asian ancestry ( Figure S1 ). We used the PC results to remove ethnic outliers (see ''GWAS Samples and Quality Control'' above), for inclusion as covariates to control for population stratification (see ''Linear Mixed Models for Estimating Case-Control Status'' below), and to divide the MGS AD sample into subsamples on the basis of degree of European admixture. After quality control, ADs were divided into overlapping subsets of decreasing degrees of European admixture, removing individuals > 2, > 1, and > 0.5 SDs above the mean AD PC1 score ( Figure S1 ).
Linear Mixed Models for Estimating Case-Control Status
For univariate heritability models, we estimated genomic similarities between pairs of individuals separately in the MGS AD sample, in the MGS ED sample, and in the ISC ED sample by using the method described by Yang et al. 23 In particular, we calculated the genomic similarity for each pair of individuals by taking the sum of the products of SNP coefficients between those individuals and then scaling that sum by the expected SNP heterozygosity,
where x il ¼ 0, 1, or 2 according to whether individual i has genotype bb, Bb, or BB, respectively, at locus l (alleles are arbitrarily called b or B), p l and q l are the allele frequencies of B and b, respectively, and 2p l is the mean of x l . These values are scaled to be both positive and negative; therefore, for clarity we use the term ''similarity'' rather than ''relationship.'' For bivariate models, we re-estimated the genomic similarities in the combined MGS AD and MGS ED samples, in the combined MGS AD and ISC ED samples, and in the combined MGS ED and ISC ED samples. In the bivariate model, the observed disease status for traits 1 and 2 can be written as
where y is a vector of observations, b is a vector of fixed covariate effects, g is a vector of genetic effects tagged by SNPs, and e is a vector of residuals. X and Z are incidence matrices for b and g, respectively. The variance covariance matrix (V) is defined as
where A is the genomic similarity relationship matrix based on SNP information across all groups, I is an identity matrix, and s are genetic variance tagged by SNPs, residual variance, and covariance between g 1 and g 2 , respectively. 18 We treated schizophrenia in each sample as a separate ''trait'' and estimated SNP heritabilities (h 1 2 and h 2 2 ) and the SNP liability covariance (cov 12 ) or SNP correlation (SNP-r g ¼ cov 12 /h 1 h 2 ) between ethnicities. 18, 23, 24 For all models, we transformed genetic-variance estimates to a liability scale by assuming a disease prevalence of 1%, as described previously, 24 and controlled for gender, 20 PCs, and site (Table 1) as covariates. Although there were large differences in average similarities of ED-AD pairs compared to withinethnicity pairs, we controlled for these differences by including ancestry PCs as fixed effects, the first of which captured the African-European gradient (see Figure S1 ). We also included PC1 2 in bivariate models in order to control for any possible ascertainment or diagnostic differences that might exist between the most and least admixed individuals. For each model, PCs included as covariates were from an IBS matrix of subjects included in that model. Because MAFs can vary by ethnicity, for bivariate models, elements in the A matrix were standardized with expected allele frequencies that varied by data set.
In the current context, SNP heritability refers to the proportion of phenotypic variance in liability to schizophrenia that is explained by the additive effect of all SNPs together, and SNP correlation refers to the additive genetic correlation (explained by all SNPs together) between the liability of schizophrenia in ADs and the liability of schizophrenia EDs. Evidence of a SNP correlation between ADs and EDs occurs to the degree that AD cases are more genetically similar to ED cases than to ED controls, and vice versa, after main effects of ethnicity are controlled for. Because the two traits (schizophrenia in ADs and schizophrenia in EDs) are measured on different individuals, the only link between traits is in the genomic-similarity scores for each pair of individuals. Therefore, unlike traditional (e.g., twin) models that decompose phenotypic correlations into additive genetic, nonadditive genetic, and environmental sources that can be mutually confounded, in the present model there is no such confounding, and SNP correlations are unlikely to be due to residual (e.g., environmental or nonadditive genetic) sources.
We used a permutation approach in which affection status was permuted within ethnicity in order to exclude the possibility of upward biases of SNP-heritability and SNP-correlation estimates (see Figure S2 ). In addition, because prevalence rates have been shown to vary across populations, 25 we varied this parameter across populations and found that it did not substantially alter SNP heritabilities or SNP correlations (see Figure S3 ). That SNP correlations are unaffected by prevalence-rate differences is also evident from the transformation equation in Lee et al. 18 Also, to understand whether some of the genetic overlap in schizophrenia between ED and AD samples might be due to the relatively high level of European admixture in ADs, estimated to be an average of~15%, 26 we ran additional bivariate models, each of which estimated SNP correlations between EDs and AD subsamples of higher-proportion African ancestry as judged from the first ancestry PC (see ''PC Analysis'' above). We used the likelihood-ratio test statistic to compare the fit of full models in which SNP correlations were freely estimated to the fit of reduced models in which SNP correlations were fixed to either 0 or 1. The distribution of differences in log likelihoods between full and reduced models is approximately chi-square distributed with 1 degree of freedom.
Binning SNPs by Rates of Recombination
We examined whether SNPs in regions of high recombination showed lower SNP correlations than SNPs in regions of low recombination. To do this, we used recombination rates estimated from CEU, YRI, and JPTþCHB HapMap populations on 3,303,900 17 The schizophrenia-liability SNP correlation captured by autosomal SNPs between the sexes was high (SNP-r g ¼ 0.70) among ADs, although a strong conclusion is not possible given the large SE (0.51) around the SNP-r g estimate. Nevertheless, this estimate is consistent with the between-sex genetic correlation we previously reported for schizophrenia in a much larger sample of EDs (SNP-r g ¼ 0.89, SE ¼ 0.06). To assess whether SNP heritability differed by functional annotation of SNPs, we partitioned the variance explained by SNPs into three components by creating genomic-similarity matrices of SNPs in genes expressed in the CNS, those found in other genes, and those not localized to genes. The proportion of SNP heritability estimated from SNPs in genes expressed in the CNS was 30% for ADs, and although large SEs do not allow us to distinguish whether this is significantly greater than the 20% of the genome these SNPs represent (SE ¼ 0.18, p (30% ¼ 20%) ¼ 0.30), these results are also consistent with those we reported previously for EDs (31%, SE ¼ 0.02, p (31% ¼ 20%) ¼ 7.6 3 10 À8 ; see Table S2 ).
The main goal of our analysis was to understand the degree to which genetic variation tagged by SNPs is shared between ED and AD populations. To do this, we estimated the SNP correlation (SNP-r g ) for schizophrenia between ethnicities. SNP correlations were estimated as SNP-r g ¼ 0. Table 2 ). In follow-up analyses, controlling for 6 rather than 20 PCs made little difference to SNP-heritability or SNP-correlation estimates (Table S3) . By excluding one chromosome and rerunning these models 22 times, we found no evidence that any individual chromosome disproportionately influenced SNP-heritability or SNPcorrelation estimates (Table S4) .
Compared to SNPs with low MAF, SNPs with high MAF typically better tag high-MAF causal variants, which are more likely to predate the African-European divergence. We therefore predicted that the genetic correlation between EDs and ADs would be higher for high-MAF SNPs than for low-MAF SNPs. Consistent with this expectation, SNP-correlation estimates derived from genomic-relationship matrices restricted to SNPs with above-median MAFs (MAF > 0. Table 3 ). We observed that SNP heritabilities were lower for above-median-MAF (h 2~0 .13) than for below-median-MAF (h 2~0 .23) SNPs among MGS ADs, although these estimates were not significantly different from each other and are consistent with random fluctuations in estimated effects across models using different genomic-relationship matrices.
On the other hand, we found no strong evidence supporting the prediction that SNP-correlation estimates would be higher in low-recombination regions (SNP-r g ¼ 0.60, SE ¼ 0. Table 3 ). To examine whether some of the genetic overlap in schizophrenia between ED and AD samples might be due to the relatively high level of European admixture in ADs, estimated to be an average of~15%, 26 we rederived SNP-correlation estimates by using subsamples of ADs with increasingly lower proportions of European ancestry as judged from the first ancestry PC. We found modest but nonsignificant decreases in SNP correlation between ADs and EDs (Table 4 ). In particular, SNP-r g was estimated to be 0.46 
Discussion
Using the largest combined AD and ED schizophrenia case-control GWAS available, we have demonstrated an application that uses direct estimates of SNP correlations to quantify the amount of shared genetic variance tagged by SNPs between any two ethnically distinct populations for any trait. We found that common genetic liability to schizophrenia is largely shared across ED and primarily AD populations. Because SNPs included in GWASs are unlikely to tag the effects of rare causal variants and because rarer causal variants are increasingly likely to be population specific, these estimates of overlap are unlikely to apply to the portion of schizophrenia heritability caused by rare causal variants. Although we make no assertion that all estimated gene effects are exactly additive, these results are unlikely to be very biased by nonadditive genetic effects because, if they exist, they contribute very little to the similarity of distantly related individuals. Even for comparisons of the same trait within an ethnicity, SNP correlations between different samples are typically less than 1 as a result of loss of real signal (e.g., greater ethnic, phenotypic, and environmental homogeneity within samples) and potential artifacts that can inflate the unshared portions of heritability (e.g., SNP calling or plate confounds that differ systematically between cases and controls). Artifacts are expected to deflate, not inflate, SNP correlations because random directional effects of artifacts are not expected to be consistent across data sets. Because MGS ADs, MGS EDs, and ISC EDs were all collected in different labs and genotyped on separate plates, the SNP correlation between MGS EDs and ISC EDs provides an upper limit on the potential SNP correlation between MGS ADs and MGS or ISC EDs. Given that SNP correlations between samples drawn from the same population are expected to be 1 in the absence of artifacts, we estimate that the SNP correlation might be as high as approximately 0.75 (0.61/0.83 or There are two principal reasons why genetic correlations across ethnicities are expected to be lower than those within ethnicities. First, some causal variants might have different effects across ethnicities (e.g., because of differences in environmental or genetic backgrounds), and some might be population specific if they arose or were lost after the European-African divergence thought to have occurred 50-100K years ago. [28] [29] [30] Our finding that high-MAF SNPs show greater SNP correlations than low-MAF SNPs lends some support to the hypothesis that lower-MAF schizophrenia causal variants are increasingly population specific and/or are differentially tagged by SNPs across ethnicities. Second, lower SNP correlations should occur to the degree that LD between causal variants and the SNPs that predict them differs across ethnicity. However, we did not find strong evidence that SNP correlations were lower for high-recombination regions than for low-recombination regions, which might be expected if differing LD patterns reduce the SNP correlation between EDs and ADs. Nonetheless, our results do not allow us to reliably quantify the relative importance of these two alternatives. Two limitations to our analysis are worth noting. First, the AD sample size in particular was small, leading to large SEs around estimates of both SNP heritabilities and SNP correlations between ethnicities. This means that we cannot place great confidence in the specific estimates of SNP correlation, and we reiterate that these parameters reflect the allelic spectrum captured by common SNPs and so might not generalize to the covariance attributable to variants in low LD with common SNPs. Nevertheless, our results suggest that there is substantial overlap of variants tagged by common SNPs between ethnic groups (with 95% confidence that SNP-r g has a lower bound of 0.20) and allow us to rule out the possibility of no overlap with even greater confidence. Second, no AD replication GWAS data set of sufficient size exists for this or any other psychiatric disorder, highlighting the importance of further large-scale genome-wide data collection in non-ED samples.
In summary, we have demonstrated how a randomeffects modeling approach fitting all SNPs simultaneously can elucidate the degree to which additive genetic variation tagged by SNPs is shared between ethnically divergent populations. We estimate that about half to three-quarters of such additive genetic variation underlying the risk of schizophrenia is shared between AD and ED populations, suggesting that schizophrenia GWAS discoveries from European samples are likely to be relevant to AD populations and that meta-analyses of schizophrenia can improve power by including results across both ED and AD samples. These conclusions should apply even more strongly to other ethnic groups given their more recent divergence times from the European lineage. Because it is vanishingly unlikely that different causal variants between ethnicities would systematically be in LD with the same SNPs, these findings suggest that many schizophrenia causal variants are ancient and predate European-African divergence.
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